Ellen Kuhl named director of Stanford Bio-X
March 29, 2024 - Stanford News
Kuhl aims to continue Bio-X’s legacy of facilitating multidisciplinary fundamental research and innovation.
Stanford Bio-X affiliated faculty members and fellows are generating scientific advances that expand our understanding of how the body works and will ultimately improve human health. These news stories and press releases describe some of those breakthroughs.
-
2024-2025 RFP NOW LIVE! Visiting Scholar or Visiting Postdoc Fellowships @ Stanford Bio-X funded by Novo Nordisk Foundation
Call opens: November 6, 2024
Call deadline: January 29, 2025 (2pm CET)
RFP GOES LIVE NOV. 6: the Stanford Bio-X Program and the Novo Nordisk Foundation are opening their call for applications for the Visiting Scholar or Visiting Postdoc Fellowships @ Stanford Bio-X! -
Apply for the 2025 Stanford Sapp Family CS Bio-X Undergraduate Summer Research Program!
October 15, 2024
Applications for the 2025 Stanford Sapp Family CS Bio-X Undergraduate Summer Research Program are due Thursday, January 16, 2025, at 8am PST! -
CeriBell, Inc., launched from a Stanford Bio-X Seed Grant, CeriBell rang the bell at Nasdaq and debuted as a public company trading!
October 11, 2024
In 2012, Stanford Bio-X affiliated faculty members Josef Parvizi and Chris Chafe received a Stanford Bio-X Seed Grant to create a stethoscope device for the brain. This Seed Grant launched CeriBell, Inc. – which made its market debut on Friday, October 11 in an IPO that is expected to generate $180.3 million in proceeds! -
Inside four undergrads’ summer research at Stanford
September 30, 2024 - Stanford News
Isabel Cai and Remington Graham, and Stanford Bio-X Undergraduate Summer Research Program Participants Nicholas Neoman and Selena Niemi, spent the break going deep into rare blood diseases, international powers, virtual reality, and sustainability. -
MicroDicer and microGrater make quick work of tumor dissection
September 10, 2024 - Stanford News
Two new biology lab tools will help researchers quickly turn out scores of uniformly sized tissue samples to study many therapies at once. The work was partially supported by a Stanford Bio-X Seed Grant! -
Stanford Bio-X Seed Grant leads to first new clinical imaging platform in a quarter-century
August 27, 2024 - Stanford News
A clinical imaging system recently designated by the FDA as a “breakthrough device” uses optical and AI technologies pioneered at Stanford to help diagnose skin cancers in real time. This discovery was launched by a Stanford Bio-X Seed Grant! -
Announcing the 2024 Stanford Bio-X Undergraduate Summer Research Program Cohort!
June 24, 2024
Stanford Bio-X is delighted to announce the 2024 Stanford Bio-X Undergraduate Summer Research Program (USRP) cohort! -
Announcing the 2024 Stanford Bio-X PhD Fellows!
June 6, 2024
Stanford Bio-X is delighted to announce the 2024 cohort for the Stanford Bio-X PhD Graduate Student Fellowships. -
Sergiu Pasca Wins the 2024 Schaller Prize for Translational Neuroscience
June 4, 2024
Stanford Bio-X affiliated faculty member and Clark Center building resident faculty Sergiu Paşca has won the 2024 Chica and Heinz Schaller Foundation Award in Translational Neuroscience. -
Stanford faculty elected to National Academy of Sciences
May 1, 2024 - Stanford Report
The National Academy of Sciences (NAS) announced 124 newly elected members, of which seven are Stanford University researchers, including Stanford Bio-X affiliated faculty members Zhenan Bao, Suzanne Pfeffer, Jennifer Raymond, and Joanna Wysocka. -
Five Stanford undergraduates named 2024 Goldwater Scholars
April 30, 2024 - Stanford Report
The national award encourages outstanding students to pursue research careers in the natural sciences, engineering, and mathematics. The five Stanford undergraduates awarded include Stanford Bio-X Undergraduate Summer Research Program participants Cyrus Hajian and Jaeah Kim. -
Seven Stanford faculty members elected to the American Academy of Arts & Sciences
April 18, 2024 - Stanford Report
Faculty from across disciplines were honored by the American Academy of Arts & Sciences, recognizing their excellence and leadership in work that advances the common good. The seven Stanford faculty elected include Stanford Bio-X affiliated faculty members Daniel Ho, Michael Frank, and Christine Jacobs-Wagner. -
Brain organoids and assembloids are new models for elucidating, treating neurodevelopmental disorders
April 24, 2024 - Stanford Medicine News Center
Research from Stanford Bio-X affiliated faculty member and Clark Center building resident faculty Sergiu Pasca and Stanford Bio-X affiliated faculty member John Huguenard, with co-author Stanford Bio-X Undergraduate Summer Research Program participant Zuzana Hudacova, with co-lead authors Dr. Xiaoyu Chen and Dr. Fikri Birey, on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions. -
Seven Stanford faculty named AAAS Fellows
April 18, 2024 - Stanford Report
Seven Stanford faculty are among the 502 new fellows of the American Association for the Advancement of Science, including Stanford Bio-X affiliated faculty members Bali Pulendran, Robert Waymouth, and Tony Wyss-Coray. -
‘Virtual biopsy’ lets clinicians analyze skin noninvasively
April 10, 2024 - Stanford Medicine News Center
Stanford Bio-X affiliated faculty member and previous Stanford Bio-X fellow Adam de la Zerda and Stanford Bio-X affiliated faculty members Kavita Sarin and Steve Chu, with lead author Stanford Bio-X Fellow Yonatan Winetraub and co-author Travel Award recipient Itamar Terem, develop a new imaging method to create a cell-by-cell reconstruction of skin or other tissue without taking a biopsy. -
Stanford Medicine study flags unexpected cells in lung as suspected source of severe COVID
April 10, 2024 - Stanford Medicine News Center
Stanford Bio-X affiliated faculty members Catherine Blish, Mark Krasnow, Peter Kim, W. E. Moerner, Christin Kuo, Julia Salzman, Stephen Quake, Joseph Shrager, and Irving Weissman, with co-lead authors Stanford Bio-X Fellow Timothy Wu, Dr. Kyle Travaglini, and Dr. Arjun Rustagi, as well as co-authors Stanford Bio-X Fellows Aaron Wilk and Daniel Liu have found a previously overlooked type of immune cell allows SARS-CoV-2 to proliferate. The discovery has important implications for preventing severe COVID-19. -
A quarter century of Bio-X community science
March 26, 2024 - Stanford News
After 25 years of transformational research, Stanford Bio-X is still fueling new ideas and changing lives through a scientific community like no other. -
Weight loss caused by common diabetes drug tied to “anti-hunger” molecule in study
March 18, 2024 - Stanford Medicine News Center
A Stanford Medicine study from Stanford Bio-X affiliated faculty members Jonathan Long and Joshua Knowles, with co-authors Stanford Bio-X Fellow Veronica Li and Stanford Bio-X Travel Award recipient Wei Wei, found that metformin, a commonly prescribed diabetes drug associated with moderate weight loss, stimulates production of lac-phe, a molecule abundant after exercise. -
Going atom-by-atom, Stanford researchers craft a new precision drug for fighting COVID-19
March 13, 2024 - Stanford News
The rapidly evolving SARS-CoV-2 virus threatens the progress made in curbing the COVID-19 pandemic. Stanford Bio-X affiliated faculty member Michael Lin and Novo Nordisk Foundation-sponsored Stanford Bio-X Visiting Scholar Michael Westberg have developed a promising novel drug candidate, designed at the atomic level, that could help doctors halt the rise of lethal new drug resistant variants. Co-authors include Stanford Bio-X affiliated faculty members Shirit Einav and Catherine Blish and Stanford Bio-X Fellows Xinzhi Zou and Yan Wu. -
New high-speed microscale 3D printing technique
March 13, 2024 - Stanford News
At their Clark Center lab, Stanford Bio-X affiliated faculty member Joseph DeSimone lead author Stanford Bio-X Travel Award recipient Jason Kronenfeld, and co-author Stanford Bio-X Travel Award recipient Max Saccone have developed a new process for microscale 3D printing creates particles of nearly any shape for applications in medicine, manufacturing, research and more – at the pace of up to 1 million particles a day. -
Smaller, more powerful stretchable electronics for wearables and implantables
March 13, 2024 - Stanford News
Stanford Bio-X affiliated faculty member Zhenan Bao, with co-authors Stanford Bio-X Travel Award recipients Weichen Wang, Xiaozhou Ji, Theodore Gao, Yu Zheng, and Zhiao Yu, with co-first authors Dr. Donglai Zhong, Dr. Can Wu, and Stanford Bio-X Travel Award recipient Dr. Yuanwen Jiang, have developed soft integrated circuits that are powerful enough to drive a micro-LED screen and small enough to read thousands of sensors in a single square centimeter. -
Our bacteria are more personal than we thought, Stanford Medicine-led study shows
March 12, 2024 - Stanford Medicine News Center
Stanford Bio-X affiliated faculty member Michael Snyder, with co-lead authors Drs. Xin Zhou and Xiaotao Shen, and colleagues tracked the gut, mouth, nose and skin bacteria of 86 people for as long as six years to try to gauge what constitutes a healthy microbiome. -
Study details how low humidity could be a boon for viruses
March 12, 2024 - Stanford News
New Stanford research from Stanford Bio-X affiliated faculty member and Clark Center building resident faculty member Dick Zare, with first author Dr. Mohammad Mofidfar, adds to evidence that the seasonality of respiratory illnesses, like COVID-19 or the flu, can be linked to indoor humidity levels. The study, which found that ventilation reduces the presence of naturally occurring disinfectant compounds in airborne microdroplets, could add another dimension to public health approaches to seasonal viruses. -
Understanding an overlooked hotspot for carbon emissions
March 11, 2024 - Stanford Doerr School of Sustainability News
Researchers have found that one-third of the organic carbon leached from peatland soils into canal waters in Southeast Asia gets broken down and released into the atmosphere as carbon dioxide.
-
A newly published protein structure helps explain how some anti-cancer immunotherapy treatments work
March 11, 2024 - Stanford News
A molecular “snapshot” of a protein can be critical to understanding its function. Stanford Bio-X affiliated faculty member Jennifer Cochran, Stanford Bio-X Fellow Jack Silberstein, and Stanford Bio-X Undergraduate Summer Research Program participant Jessica Frank, as well as co-authors at Stanford and NYU, have published and investigated a new structure of the protein LAG-3, which could enable the development of new cancer treatments. -
Model estimates who benefits most from frequent COVID-19 boosters
March 6, 2024 - Stanford Medicine News Center
A study led by Stanford Bio-X affiliated faculty member Nathan Lo, with lead author Hailey Park, finds the benefit of frequent booster vaccination for COVID-19 is highest for those over 65 years and the immunocompromised. -
Researchers dial in on genetic culprit of disease
March 5, 2024 - Stanford Medicine Scope
New research from Stanford Bio-X affiliated faculty member and previous Stanford Bio-X Undergraduate Summer Research Program participant Jesse Engreitz, with co-lead authors Dr. Gavin R. Schnitzler and Helen Kang, finds that genome-wide association studies can lay the groundwork to more precisely assess a person’s risk for disease, detect diseases earlier, reveal a molecular understanding of how certain illnesses arise, and point to new therapeutic targets. -
25th Anniversary of Stanford Bio-X and 20th Anniversary of the James H. Clark Center
This year marks the 25th anniversary of the Stanford Bio-X program and the 20th anniversary of the Clark Center building! Read the feature story and check out the timeline to celebrate with us!
-
A new RNA editing tool could enhance cancer treatment
February 21, 2024 - Stanford News
The new study from Stanford Bio-X affiliated faculty members Stanley Qi and Crystal Mackall and Stanford Bio-X Fellow Crystal Chen, with lead author Stanford Bio-X Fellow Victor Tieu, found that an RNA-targeting CRISPR platform could tune immune cell metabolism without permanent genetic changes, potentially unveiling a relatively low-risk way to upgrade existing cell therapies for cancer. -
Stanford Medicine study identifies distinct brain organization patterns in women and men
February 20, 2024 - Stanford Medicine News Center
Stanford Bio-X affiliated faculty member Vinod Menon, with co-lead authors Drs. Srikanth Ryali and Yuan Zhang, has developed a powerful new artificial intelligence model that can distinguish between male and female brains.